SeekIn receives CE Mark for cancer detection kit

2019 07 15 18 08 8235 Artificial Intelligence Ai Data 400

SeekIn has received the CE Mark for its SeekInCare cancer detection kit, which is ready to be launched in European markets.

The company has an artificial intelligence (AI)-based platform that uses private and public data to identify weak cancer DNA and protein signals in the blood and trace them back to a tissue of origin. SeekIn also has patents on algorithms to reduce background noise and reveal cancer signals in blood.

Page 1 of 16
Next Page